Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial Medical Dialogues Bureau3 Nov 2019 3:30 AM GMTBristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
SETBACK: Novartis Zolgensma study halted by USFDA amid safety concerns Medical Dialogues Bureau31 Oct 2019 4:15 AM GMTNovartis shares fell 1% at 0715 GMT, while other European drugmakers rose. Analysts said more information was needed to assess whether these findings...
CDSCO committee tells Roche to submit Phase III clinical trial data of blood cancer combo drug Farhat Nasim27 Oct 2019 6:00 AM GMTNew Delhi: The Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO), recently recommended drugmaker,...
Roche Tecentriq, Avastin combo to increase overall survival, progression-free survival in HCC Medical Dialogues Bureau22 Oct 2019 4:20 AM GMTRoche, in its recent release, in 2018, the U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy Designation (BTD) for Tecentriq in...
Roche gets USFDA clearance for cobas pro solutions for diagnostics labs Medical Dialogues Bureau17 Sep 2019 3:45 AM GMTWith the cobas pro integrated solutions, laboratories are now able to run tests faster on less equipment, automate manual tasks and deliver results...
Roche touts drugs pipeline, rules out Merger and Acquisition just to boost sales Medical Dialogues Bureau7 Sep 2019 3:45 AM GMTRoche has twice upgraded 2019 sales forecasts, the latest time to mid- to high-single-digit percentage rate growth, as medicines including Ocrevus for...
Roche names Eli Lilly executive Levi Garraway as chief medical officer Medical Dialogues Bureau20 Aug 2019 3:30 AM GMTLevi Garraway, most recently Eli Lilly's senior vice president, oncology research and development and Lilly research laboratories novel target...
Roche personalized cancer treatment Rozlytrek priced at Rs 12 lakh per month Medical Dialogues Bureau17 Aug 2019 3:45 AM GMTRozlytrek was approved by the U.S. Food and Drug Administration on Thursday to treat certain types of solid tumours, which show rare genetic anomalies...
Sanofi strikes deal for US rights to Roche Tamiflu Medical Dialogues Bureau24 July 2019 3:45 AM GMTUnder the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
Single dose of Xofluza flu drug as effective as Tamiflu in kids, says Roche Medical Dialogues Bureau6 July 2019 3:45 AM GMTXofluza, an oral treatment, was well tolerated in children, said Roche, whose medicine is already approved broadly in Japan and for people older than...
Roche wins Japan approval for personalised cancer drug Rozlytrek Medical Dialogues Bureau19 Jun 2019 6:31 AM GMTZURICH: Swiss drugmaker Roche on Tuesday won approval in Japan for Rozlytrek as the world's biggest maker of cancer drugs pushes ahead in personalised...
Roche appoints Thomas Schinecker as new head of $13 billion diagnostics unit Medical Dialogues Bureau12 Jun 2019 4:00 AM GMTRoche's new diagnostics boss, Thomas Schinecker, fills a post that had been led for months on an interim basis by Michael Heuer, who is retiring....
